Faron Announces Release of Research Confirming Bexmarilimab

FINLAND - Faron Pharmaceuticals Oy , a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, today announces the release of further insights from its Phase... | April 25, 2023

Related Keywords

Finland , Maija Hollmen , Jennifer Smith Parker , Faron Pharmaceuticals Oy , First North , Chief Scientific Officer , Common Lymphatic Endothelial , Vascular Endothelial Receptor , News Publishing , Faron Pharmaceuticals Oy Stock Exchange , News , Information , Press Release , Aaron , Pharmaceuticals , Y , Iopharmaceutical , Company , Ocused , N , Tackling , Cancers , Cia , Novel , Oday , Nnounces , The , Release , F , Urther , Insights , Rom , Ts Farn Fi4000153309 ,